Avillion Life Sciences
PrivateLast Round
Early Funding
May 6, 2014
Company Overview
Avillion Life Sciences operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was an Early Funding round in May 2014.
Avillion Life Sciences is a pharmaceutical development company that provides clinical development expertise and funding to partner with biotech and pharmaceutical companies to accelerate drug development programs.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Biotechnology, Compliance & Risk
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avillion Life Sciences Comparables
Compare Avillion Life Sciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SFJ Pharmaceuticals | 93% | |
| Launch Therapeutics | 86% | |
| Carlyle Group | 79% |
For institutional investors. Book with your work email.
Avillion Life Sciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | May 6, 2014 | ||||
| VC Round | Jan 28, 2013 |
For institutional investors. Book with your work email.
Avillion Life Sciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Abingworth | VC Round, Early Funding |
| Royalty Pharma | Early Funding |
| Blackstone Life Sciences | VC Round, Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
Monthly visitors increased 164% MoM.
- Jan 19, 2026
Monthly visitors increased 59% MoM.
For institutional investors. Book with your work email.
Avillion Life Sciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Avillion Life Sciences's valuation, stock price, and market status.
Is Avillion Life Sciences a public or private company?
Avillion Life Sciences is a private company.
What is the current stock price of Avillion Life Sciences?
Avillion Life Sciences is a private company, so its shares have no public market price. Caplight tracks Avillion Life Sciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Avillion Life Sciences worth (valuation)?
Valuation information for Avillion Life Sciences is not publicly available.
Can I buy Avillion Life Sciences stock?
Avillion Life Sciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Avillion Life Sciences's last funding round?
Avillion Life Sciences's most recent funding round was Early Funding on May 6, 2014.
Who are the main investors in Avillion Life Sciences?
Key investors in Avillion Life Sciences include Abingworth, Royalty Pharma, Blackstone Life Sciences.
Will Avillion Life Sciences IPO soon?
No public IPO plans have been announced for Avillion Life Sciences.
How can I track Avillion Life Sciences secondary market activity?
Caplight tracks bids, offers, and trades in Avillion Life Sciences's shares on secondary markets.